Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sacubitril/valsartan on Left Ventricular Extracellular Volume in HFrEF
jRCT1041210066Completed
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sacubitril + valsartan in chronic heart failure (CHF) and heart failure with reduced ejection fraction (HFrEF) (2 arms). Primary endpoint: Change in extracellular volume fraction (ECV). Started Oct 2021; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic heart failure (CHF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on jRCT1041210066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041210066.